Formulation products
-
Urokinase for injection
The product is mainly used for thrombolytic therapy of thromboembolic diseases. These include acute generalized pulmonary embolism, coronary artery embolism and myocardial infarction within 6-12 hours of chest pain, acute cerebrovascular embolism with symptoms shorter than 3-6 hours, retinal artery embolism and other peripheral artery embolism symptoms of severe skeletal vein thrombosis. It is also used to prevent thrombosis after prosthetic heart valve surgery, and to keep vascular cannulation and thoracic and pericardial drainage tubes unobstructed. Thrombolytic efficacy requires subsequent heparin anticoagulation to maintain.
-
Chorionic Gonadotrophin for injection
Indications
1. Diagnosis and treatment of prepubertal cryptorchidism.
2. Male infertility caused by hypopituitarism can be combined with urogonadotropin. Long-term hypogonadotropin function. It should also be supplemented with testosterone therapy.
3. Anovulatory infertility in women caused by pituitary gonadotropin insufficiency is often combined with urogonadotrophin to promote ovulation after clomiphene treatment is ineffective.
4. Used for in vitro fertilization to obtain multiple oocytes, in combination with menotrophin.
5. Treatment of luteal insufficiency in women.
6. Functional uterine bleeding, threatened miscarriage in the first trimester, recurrent miscarriage.